[A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D011718:Pyrazinamide; D012293:Rifampin